Researchers find natural mechanism to sensitize cancer to immunotherapy

A study defines how a type of cell death occurs from a protein and fatty acid found inside the body.

8:52 AM

Author | Anna Megdell

cell in red with black background with lab note written

Researchers at the University of Michigan Rogel Cancer Center found that a cytokine, a category of protein that acts as messengers in the body, and a fatty acid can work together to trigger a type of cell death previously defined by studies with synthetic molecules.

The study, published in Cancer Cell, looked at cell cultures and in vivo mouse experiments to see how the release of a T-cell cytokine called interferon gamma combined with arachidonic acid, a fatty acid, leads to a type of cell death called ferroptosis via  targeting the enzyme ACSL4. Ferroptosis has been found to occur in tumor cells and play a role in cancer immunity. Understanding how ferroptosis occurs could open pathways to make immunotherapy treatments more effective. 

"Targeting ACSL4 may help in understanding and expanding possible immunotherapy options," said Weiping Zou, M.D., Ph.D., director the Center of Excellence for Cancer Immunology and Immunotherapy and lead researcher on this study.

Zou explains that this natural mechanism begins when activated T-cells release interferon gamma, a signaling protein. "It's well known that interferon gamma is involved in anti-tumor responses," said Zou. "But in this study, we defined a new way that it works."

This study shows that combining interferon gamma with arachidonic acid, a fatty acid found in the tumor microenvironment, activates ACSL4, alters tumor cell lipid pattern, and naturally induces tumor cell ferroptosis. "ACSL4-dependent tumor ferroptosis is a mode of action of killer T cells," said Zou. "Targeting ACSL4 sensitizes cancer to immunotherapy."

Zou's lab was the first to identify a role for ferroptosis in cancer immunity and therapy, highlighting the possibility of targeting this pathway to improve the effectiveness of immunotherapy in people with cancer. While immunotherapy has dramatically changed outcomes in melanoma, lung cancer and other cancer types, the treatments work for only about 30% of people with cancer.  

These new findings add more knowledge to how ferroptosis works in patients with cancer, which Zou hopes will prompt further investigation.

"This study raises a lot of questions for us to keep exploring, particularly around the basic biology of cell ferroptosis, including the involvement of different fatty acids and dietary lipids, the different roles immune cells play in ferroptosis, and how to target ACSL4 and ferroptosis pathways," Zou said. "For now, there are many unknowns, but we'll continue to work in this space."

Paper cited/DOI: "CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4," Cancer Cell. DOI: 10.1016/j.ccell.2022.02.003

More Articles About: Lab Notes Basic Science and Laboratory Research All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories Microscope
Health Lab
Studying a protein modification process in worms provides potential insights for human health
Too much of this post-translational modification impacted multiple body systems
small intestine drawing lab notes
Health Lab
How the western diet and gut bacteria can lead to scarring, vessel damage in scleroderma
The same metabolite is linked to cardiovascular and metabolic diseases.
brain lab note
Health Lab
Early blood tests predict death, severe disability for traumatic brain injury
In the study, the method predicted poor outcomes six months after injury with high accuracy.
myeloma purple green
Health Lab
Researchers find link between genetic mutations and cancer treatment resistance
Patients with relapsed multiple myeloma are resistant to commonly used treatments. Researchers are one step closer to understanding the genetic reason why.
heart image lab note navy blue yellow
Health Lab
Thyroid hormone treatment intensity linked to increased risk of cardiovascular mortality
The findings highlight the importance of regular monitoring of thyroid function and prompt correction of over- and under-treatment with thyroid hormone to reduce patient harm.
lungs drawing yellow blue lab note
Health Lab
New option for control of severe asthma, lung microbiome and transplant and more
Highlights from the American Thoracic Society 2022 Conference from Michigan Medicine researchers.